Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6521
    +0.0021 (+0.32%)
     
  • OIL

    82.92
    +0.11 (+0.13%)
     
  • GOLD

    2,334.20
    -4.20 (-0.18%)
     
  • Bitcoin AUD

    98,011.71
    -4,265.21 (-4.17%)
     
  • CMC Crypto 200

    1,388.98
    +6.41 (+0.46%)
     
  • AUD/EUR

    0.6084
    +0.0014 (+0.23%)
     
  • AUD/NZD

    1.0951
    +0.0009 (+0.08%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,077.62
    +37.24 (+0.46%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    17,999.85
    -88.85 (-0.49%)
     
  • Hang Seng

    17,267.10
    +65.83 (+0.38%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie

Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie

Vertex Pharmaceuticals (NASDAQ: VRTX) and AbbVie (NYSE: ABBV) both beat last year's bear market. Vertex and AbbVie also happen to offer a lot of growth potential. Vertex has a new potential blockbuster drug on the horizon.